0
Cancer Research: What is the sensitivity and specificity of the BRCA1 and 2 mutations?
- 1 people answered
0 Vote
1 Contributor
1875 Views 
0 Saved
0 Vote 1 Contributor1875 Views 0 SavedYou might also be interested in
Yes, PARP inhibitors are relatively newer class of drugs and scientists have just begun to explore their functionality and usage in Cancer treatment. LYNPARZA is the first and only PARP inhibitor approved in 2 distinct settings: For the maintenance treatment of adult patients with recurrent epitheli....
No, but. Cancer during pregnancy is not an uncommon thing but cancer itself rarely affects the growing baby directly. The cancers that tend to occur during pregnancy are also more common in younger people. These cancers include - Cervical Cancer, Breast Cancer, Thyroid Cancer, Melanoma, Gestat....
Direct breastfeeding could cut the chance of breast cancer by up to one fifth. It’s actually a “powerful strategy” to reduce the risk of cancer for you, especially the most aggressive types of disease. Scientists believe the high hormone levels required for lactation appears to affect cell growth, p....
Nidii Berwal
Genes and genetic variations in our body contribute to the bodily functions and overall health. This also includes the possibility of having various diseases which are hereditary or developed in our body due to changes in the genetic codes. BRCA -1 & BRCA – 2 are two genes which are linked to Hereditary Breast and Ovarian Cancer. These genes produce tumor suppressor proteins which help to repair damaged DNA. When either of these genes have mutations, it increases the risk of cancer. BRCA 1 & BRCA 2 testing should be considered if: You had breast cancer at early age Your mother, sister, or daughter had breast cancer at early age or ovarian cancer. You are a woman with 1st degree relative who’s diagnosed with bilateral breast cancer before age of 50 The men in your family have strong history of breast/ ovarian cancer. Women who have BRCA 1 gene mutation are at higher risk of triple negative breast cancer while BRCA 2 carriers have breast cancers that are Estrogen Receptor positive. BRCA 1/2 mutations increase the risk of ovarian cancer.